Questions pharma teams ask before bringing CLEVAIR into live HTA work

CLEVAIR-HTA has been built specifically to address EU HTA Regulation 2021/2282 and support the JCA process from evidence strategy to submission-ready dossier in one continuous workflow. It is not a generic prompting layer. It keeps comparator logic, evidence, drafting, review, and approvals connected in one governed working model.

CLEVAIR supports the workflow from project setup and horizon scanning through comparator development, evidence operations, PICO work, drafting, and live review. The goal is to keep those stages connected so your team can move from evidence strategy to submission-ready output in one continuous workflow.

CLEVAIR helps teams carry one logic across the workflow instead of treating each stage as a separate process. Comparator decisions, PICO framing, evidence operations, drafting, and review stay connected. That means less manual rebuilding, less duplicated effort, and a clearer path from validated evidence to dossier output.

CLEVAIR is designed so expert review stays explicit. Your team can see where comments were made, how decisions evolved, and where human approval was applied. The system is meant to accelerate structured work, not to hide critical HTA judgment behind opaque outputs.

Traceability comes from keeping source material, workflow stages, draft outputs, reviewer comments, and approvals connected inside the same workflow. That helps your team understand where outputs came from, what changed, and how final content was shaped.

CLEVAIR gives cross-functional teams one shared working model instead of separate files, side notes, and disconnected review loops. That makes ownership clearer and helps evidence, drafting, and review move forward without losing context between teams.

CLEVAIR is designed to reduce the cost of late changes by keeping decisions, source context, and draft outputs linked throughout the workflow. When scope changes happen, your team can see what was affected and update from a controlled baseline rather than restarting from scratch.

Yes. CLEVAIR supports national-to-EU thinking by helping teams reconcile local comparator and evidence logic before carrying it into a more consistent JCA execution model. It can also support post-JCA follow-through when national dossiers, affiliate adaptation, and payer responses still need structured execution.

A team can start where execution pressure is highest first, then expand once value is proven on live work. The right starting point depends on where your workflow is currently losing time or control, which is why the next step is usually a tailored demo around your current process.